Related Experiment Video
Updated: Jan 21, 2026

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
ALS/SURV: a modification of the CAFS statistic
Stephen A Goutman1,2, Morton B Brown3, Merit Cudkowicz4
1Department of Neurology, University of Michigan , Ann Arbor , MI , USA.
A new composite endpoint, ALS/SURV, combines functional status and survival for amyotrophic lateral sclerosis (ALS) trials. It improves participant ranking, especially for those withdrawing, offering a more robust measure than CAFS.
Area of Science:
- Neurology
- Clinical Trials
- Biostatistics
Background:
- Amyotrophic lateral sclerosis (ALS) clinical trials require robust endpoints to assess treatment efficacy.
- Existing composite endpoints like CAFS may not adequately account for participant withdrawal or loss to follow-up.
- Accurate assessment of functional status and survival is crucial for evaluating interventions in ALS.
Purpose of the Study:
- To introduce and validate a novel composite endpoint, ALS/SURV, for amyotrophic lateral sclerosis (ALS) trials.
- To compare the performance of ALS/SURV against the Combined Assessment of Function and Survival (CAFS) score, particularly regarding participant dropout.
- To establish ALS/SURV as a statistically sound and clinically meaningful measure for ALS research.
Main Methods:
- Developed ALS/SURV by modifying and extending the CAFS score to incorporate functional status (ALS Functional Rating Scale) and survival.
- Implemented a ranking system within ALS/SURV that appropriately handles participants who withdraw or are lost to follow-up.
- Applied ALS/SURV and CAFS to data from a ceftriaxone treatment trial for ALS to compare participant rankings.
Main Results:
- ALS/SURV provides a ranking system that orders participants based on survival and functional status, without disproportionately skewing results due to dropouts.
- Comparison with CAFS demonstrated that ALS/SURV does not alter the study completion rankings based on withdrawal data.
- ALS/SURV allows for summary statistics (median, interquartile range) and enables confidence interval computation for power estimation in future studies.
Conclusions:
- ALS/SURV is a superior composite endpoint for ALS trials, offering improved handling of participant withdrawal compared to CAFS.
- The statistical properties of ALS/SURV support its use for more accurate and reliable assessment of therapeutic interventions in ALS.
- ALS/SURV provides a clinically meaningful and statistically robust measure for advancing ALS research and drug development.
Related Concept Videos
Statistical Significance
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Probability in Statistics
An example of a simple event is a coin toss. The result of a coin toss is either a head or a tail. Here, head and tail are two simple events. These two simple events make up the sample space. Further, the probability of an event occurring falls within the range of 0 to 1. The probability of an...
Introduction to Statistics
In statistics, the collection of individuals or objects under study is called population. The idea of sampling is to select a portion of the larger population...
Spreading of Chromatin Modifications
Writers
The writer...
Statistical Analysis: Overview
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...

